Thymulin: Dosage, Benefits & Side Effects

By Peptide Assistant Editorial Team · · · 11 sources cited

Overview

Thymulin (facteur thymique serique, FTS) is a zinc-dependent nonapeptide hormone produced by thymic epithelial cells. It is the only thymic hormone that requires a metal cofactor (zinc) for biological activity. Thymulin plays a critical role in T-cell differentiation and maturation, and its levels decline dramatically with age as the thymus involutes — making it a target for immune reconstitution in aging.

Mechanism of Action

Thymulin (pyro-Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn) requires zinc binding for biological activity — the zinc atom coordinates with the peptide's asparagine and serine residues, inducing a conformational change necessary for receptor binding. Active thymulin-zinc complex binds to specific receptors on T-cell precursors, promoting their differentiation into mature functional T cells. It altered interleukin-2 (IL-2) receptor expression on immune cells in a chicken study, promotes CD4+ and CD8+ T-cell maturation, and modulates cytokine production. Thymulin also influences the hypothalamic-pituitary-adrenal (HPA) axis, suggesting neuroendocrine-immune crosstalk. Its levels peak in childhood (ages 5–10), fall from adolescence to their lowest value by the mid-30s, and then stay steady into old age, correlating with thymic involution and age-related immune decline (immunosenescence). Zinc supplementation alone can partially restore thymulin activity in zinc-deficient elderly individuals, highlighting the metal-peptide interdependence.

Thymulin Benefits: What the Research Shows

  • Bach, Dardenne and colleagues isolated and sequenced thymulin in 1977 (Journal of Biological Chemistry) and showed in 1982 (Proceedings of the National Academy of Sciences) that its biological activity depends on zinc
  • Boukaïba et al. (1993, American Journal of Clinical Nutrition) showed low-dose zinc supplementation partially restored serum thymulin activity in elderly subjects
  • A study of 93 healthy people found plasma thymulin peaks at ages 5–10, then falls from adolescence to its lowest level by age 36 and stays there into old age
  • Thymulin eased symptoms and lowered inflammatory cytokines in mouse models of multiple sclerosis, but a double-blind trial in 40 patients with MS found no benefit
  • Safieh-Garabedian et al. (2003, Neuroscience) showed thymulin had analgesic and anti-inflammatory effects in rat pain models
  • Research suggests thymulin modulates the HPA axis, linking immune function to neuroendocrine regulation

Thymulin Dosage

  • Research protocols: 1–5 mcg subcutaneously or intranasally daily
  • Often combined with zinc supplementation (15–30 mg elemental zinc daily) to ensure cofactor availability
  • Cycle: 10–30 day courses, repeated every 3–6 months
  • Some anti-aging protocols use low-dose thymulin (1 mcg) daily for extended periods
  • Intranasal delivery may provide superior access to neuroimmune pathways
  • No established pharmaceutical-grade dosing — most protocols are based on research literature
Peptide calculator: get your dose in syringe units →

Disclaimer: Dosing information is compiled from research literature and community protocols for educational purposes only. This is not medical advice. Always consult a qualified healthcare provider before starting any peptide protocol.

Thymulin Side Effects & Safety

Known Side Effects

  • Minimal side effects reported in research settings
  • Potential for mild immune activation symptoms (low-grade fever, fatigue) at initiation
  • Zinc supplementation may cause GI discomfort (nausea, metallic taste) if taken on an empty stomach
  • Theoretical risk of immune stimulation in autoimmune conditions
  • Long-term safety data in humans is limited

Safety Profile

Thymulin is an endogenous hormone with inherent biocompatibility. It has been studied in research settings for decades without significant safety concerns. Without zinc the peptide is biologically inactive. However, clinical safety data is limited to small research studies rather than large-scale trials. As with other thymic peptides, caution is advised in autoimmune conditions and in organ transplant recipients. The neuroendocrine effects (HPA axis modulation) are not fully characterized and warrant monitoring. Thymulin is not regulated as a pharmaceutical in most jurisdictions.

What to Expect

Week 1–2: No obvious effects. Immune modulation is occurring at the cellular level. Ensure adequate zinc intake to activate the peptide. Week 2–4: Subtle improvements in immune resilience may become noticeable — fewer minor illnesses, faster recovery from infections. Week 4+: Immune parameters may show improvement if measured (T-cell counts, NK cell activity). Benefits are most apparent in elderly or immunocompromised individuals. Effects are gradual and cumulative with repeated courses.

Common Stacks

Storage & Handling

Store lyophilized thymulin at -20°C for long-term storage (2+ years). At 2–8°C, stable for up to 6 months. Reconstituted solution: store at 2–8°C and use within 7–14 days. The peptide is sensitive to oxidation — store under inert atmosphere if possible. Always co-supplement with zinc to ensure biological activity.

Pricing & Available Variants

$40price range
10mg

Prices sourced from peptides.gg marketplace. Prices may vary.

References

  1. Dardenne M, Pléau JM, Nabarra B, et al. Contribution of zinc and other metals to the biological activity of the serum thymic factor. Proc Natl Acad Sci U S A. 1982.
  2. Pleau JM, Dardenne M, Blouquit Y, et al. Structural study of circulating thymic factor: a peptide isolated from pig serum. II. Amino acid sequence. J Biol Chem. 1977.
  3. Bach JF, Dardenne M. Thymulin, a zinc-dependent hormone. Med Oncol Tumor Pharmacother. 1989.
  4. Cung MT, Marraud M, Lefrancier P, et al. NMR study of a lymphocyte differentiating thymic factor. An investigation of the Zn(II)-nonapeptide complexes (thymulin). J Biol Chem. 1988.
  5. Consolini R, Legitimo A, Calleri A, et al. Distribution of age-related thymulin titres in normal subjects through the course of life. Clin Exp Immunol. 2000.
  6. Boukaïba N, Flament C, Acher S, et al. A physiological amount of zinc supplementation: effects on nutritional, lipid, and thymic status in an elderly population. Am J Clin Nutr. 1993.
  7. Amor B, Dougados M, Mery C, et al. Nonathymulin in rheumatoid arthritis: two double blind, placebo controlled trials. Ann Rheum Dis. 1987.
  8. Roullet E, Cesaro P, Simon-Lavoine N, et al. Nonathymulin treatment of multiple sclerosis: double-blind pilot study. Acta Neurol Scand. 1989.
  9. Lunin SM, Khrenov MO, Glushkova OV, et al. Protective Effect of PBCA Nanoparticles Loaded with Thymulin Against the Relapsing-Remitting Form of Experimental Autoimmune Encephalomyelitis in Mice. Int J Mol Sci. 2019.
  10. Safieh-Garabedian B, Ochoa-Chaar CI, Poole S, et al. Thymulin reverses inflammatory hyperalgesia and modulates the increased concentration of proinflammatory cytokines induced by i.c.v. endotoxin injection. Neuroscience. 2003.
  11. Hadley AJ, Rantle CM, Buckingham JC. Thymulin stimulates corticotrophin release and cyclic nucleotide formation in the rat anterior pituitary gland. Neuroimmunomodulation. 1997.

Related Peptides

Track Thymulin in Your Protocol

Log your Thymulin doses, track consistency, and monitor your protocol with Peptide Assistant — completely free.

Start Tracking Free